Mark Van Oene - Mar 2, 2023 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Signature
/s/ Michele Farmer, Attorney-in-fact
Stock symbol
PACB
Transactions as of
Mar 2, 2023
Transactions value $
-$59,502
Form type
4
Date filed
3/6/2023, 03:50 PM
Previous filing
Jan 11, 2023
Next filing
Aug 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PACB Common Stock Award $0 +329K +51.04% $0.00 972K Mar 2, 2023 Direct F1, F2
transaction PACB Common Stock Sale -$59.5K -6.27K -0.64% $9.49 966K Mar 3, 2023 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on February 15th of each of 2024, 2025, 2026, and 2027, provided that the Reporting Person continues to serve through each applicable vesting date.
F2 Includes 2,831 shares purchased on March 1, 2023 under the Company's 2010 Employee Stock Purchase Plan.
F3 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F4 This sale price represents the weighted average sale price of the shares sold ranging from $9.24 to $9.71 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Remarks:

Chief Operating Officer